{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:48:57Z","timestamp":1790185737539,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001656","name":"Helmholtz-Gemeinschaft","doi-asserted-by":"publisher","award":["BioInterfaces in Technology and Medicine (BIFTM) of the Karlsruhe Institute of Technology (KIT)"],"award-info":[{"award-number":["BioInterfaces in Technology and Medicine (BIFTM) of the Karlsruhe Institute of Technology (KIT)"]}],"id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Open Access Publishing, by the Baden-W\u00fcrttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universit\u00e4t Heidelberg"],"award-info":[{"award-number":["Open Access Publishing, by the Baden-W\u00fcrttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universit\u00e4t Heidelberg"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-018-0936-8","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T13:44:20Z","timestamp":1530711860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine"],"prefix":"10.1186","volume":"9","author":[{"given":"P.","family":"Netsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Elvers-Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Huck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kirschh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Brenner-Wei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Janetzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Solz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wuchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bugert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-0703","authenticated-orcid":false,"given":"K.","family":"Bieback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"issue":"5","key":"936_CR1","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/trf.12421","volume":"54","author":"RR Sharma","year":"2014","unstructured":"Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54(5):1418\u201337.","journal-title":"Transfusion"},{"issue":"2","key":"936_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","volume":"120","author":"J Butler","year":"2017","unstructured":"Butler J, Epstein SE, Greene SJ, Quyyumi AA, Sikora S, Kim RJ, Anderson AS, Wilcox JE, Tankovich NI, Lipinski MJ, et al. Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II-A randomized trial. Circ Res. 2017;120(2):332\u201340.","journal-title":"Circ Res"},{"issue":"10051","key":"936_CR3","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388(10051):1281\u201390.","journal-title":"Lancet"},{"issue":"10","key":"936_CR4","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials Group. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7(10):e47559.","journal-title":"PLoS One"},{"issue":"9411","key":"936_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(04)15695-X","volume":"363","author":"PR Vulliet","year":"2004","unstructured":"Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 2004;363(9411):783\u20134.","journal-title":"Lancet"},{"issue":"2","key":"936_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbrc.2012.12.134","volume":"431","author":"K Tatsumi","year":"2013","unstructured":"Tatsumi K, Ohashi K, Matsubara Y, Kohori A, Ohno T, Kakidachi H, Horii A, Kanegae K, Utoh R, Iwata T, et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun. 2013;431(2):203\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"936_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","volume":"77","author":"D Furlani","year":"2009","unstructured":"Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, Wang W, Yerebakan C, Li W, Gaebel R, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009;77(3):370\u20136.","journal-title":"Microvasc Res"},{"issue":"1","key":"936_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54\u201363.","journal-title":"Cell Stem Cell"},{"issue":"13","key":"936_CR9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/hepr.12507","volume":"45","author":"S Shiratsuki","year":"2015","unstructured":"Shiratsuki S, Terai S, Murata Y, Takami T, Yamamoto N, Fujisawa K, Burganova G, Quintanilha LF, Sakaida I. Enhanced survival of mice infused with bone marrow-derived as compared with adipose-derived mesenchymal stem cells. Hepatol Res. 2015;45(13):1353\u20139.","journal-title":"Hepatol Res"},{"issue":"7323","key":"936_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/468485a","volume":"468","author":"D Cyranoski","year":"2010","unstructured":"Cyranoski D. Korean deaths spark inquiry. Nature. 2010;468(7323):485.","journal-title":"Nature"},{"key":"936_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/scrt544","volume":"6","author":"LL Cui","year":"2015","unstructured":"Cui LL, Kerkel\u00e4 E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A, Janowski M, Walczak P, Boltze J, Lukomska B, et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther. 2015;6:11.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"936_CR12","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1002\/stem.2050","volume":"33","author":"BM Gleeson","year":"2015","unstructured":"Gleeson BM, Martin K, Ali MT, Kumar AH, Pillai MG, Kumar SP, O'Sullivan JF, Whelan D, Stocca A, Khider W, et al. Bone marrow-derived mesenchymal stem cells have innate procoagulant activity and cause microvascular obstruction following intracoronary delivery: amelioration by antithrombin therapy. Stem Cells. 2015;33(9):2726\u201337.","journal-title":"Stem Cells"},{"issue":"19","key":"936_CR13","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1089\/scd.2015.0120","volume":"24","author":"G Moll","year":"2015","unstructured":"Moll G, Ignatowicz L, Catar R, Luecht C, Sadeghi B, Hamad O, Jungebluth P, Dragun D, Schmidtchen A, Ringden O. Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua. Stem Cells Dev. 2015;24(19):2269\u201379.","journal-title":"Stem Cells Dev"},{"issue":"5","key":"936_CR14","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/thno.21906","volume":"8","author":"M Oeller","year":"2018","unstructured":"Oeller M, Laner-Plamberger S, Hochmann S, Ketterl N, Feichtner M, Brachtl G, Hochreiter A, Scharler C, Bieler L, Romanelli P, et al. Selection of tissue factor-deficient cell transplants as a novel strategy for improving hemocompatibility of human bone marrow stromal cells. Theranostics. 2018;8(5):1421\u201334.","journal-title":"Theranostics"},{"issue":"8","key":"936_CR15","doi-asserted-by":"publisher","first-page":"e42819","DOI":"10.1371\/journal.pone.0042819","volume":"7","author":"X Stephenne","year":"2012","unstructured":"Stephenne X, Nicastro E, Eeckhoudt S, Hermans C, Nyabi O, Lombard C, Najimi M, Sokal E. Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity. PLoS One. 2012;7(8):e42819.","journal-title":"PLoS One"},{"issue":"7","key":"936_CR16","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/stem.1111","volume":"30","author":"G Moll","year":"2012","unstructured":"Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen AM, Elgue G, Funke L, Hamad OA, Lonnies H, Magnusson PU, Sanchez J, et al. Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells. 2012;30(7):1565\u201374.","journal-title":"Stem Cells"},{"issue":"1","key":"936_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7150\/thno.16911","volume":"7","author":"L Liao","year":"2017","unstructured":"Liao L, Shi B, Chang H, Su X, Zhang L, Bi C, Shuai Y, Du X, Deng Z, Jin Y. Heparin improves BMSC cell therapy: anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy. Theranostics. 2017;7(1):106\u201316.","journal-title":"Theranostics"},{"issue":"19","key":"936_CR18","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1089\/scd.2013.0016","volume":"22","author":"H Wegmeyer","year":"2013","unstructured":"Wegmeyer H, Broske AM, Leddin M, Kuentzer K, Nisslbeck AK, Hupfeld J, Wiechmann K, Kuhlen J, von Schwerin C, Stein C, et al. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev. 2013;22(19):2606\u201318.","journal-title":"Stem Cells Dev"},{"issue":"1 Suppl 1","key":"936_CR19","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1097\/TA.0000000000001485","volume":"83","author":"BA Christy","year":"2017","unstructured":"Christy BA, Herzig MC, Montgomery RK, Delavan C, Bynum JA, Reddoch KM, Cap AP. Procoagulant activity of human mesenchymal stem cells. J Trauma Acute Care Surg. 2017;83(1 Suppl 1):S164\u20139.","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"936_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/09205063.2012.712029","volume":"24","author":"F Wang","year":"2013","unstructured":"Wang F, Li Z, Guan J. Fabrication of mesenchymal stem cells-integrated vascular constructs mimicking multiple properties of the native blood vessels. J Biomater Sci Polym Ed. 2013;24(7):769\u201383.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"29","key":"936_CR21","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1073\/pnas.0704581104","volume":"104","author":"CK Hashi","year":"2007","unstructured":"Hashi CK, Zhu Y, Yang GY, Young WL, Hsiao BS, Wang K, Chu B, Li S. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A. 2007;104(29):11915\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"936_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jcyt.2013.01.215","volume":"15","author":"K Bieback","year":"2013","unstructured":"Bieback K, Vinci M, Elvers-Hornung S, Bartol A, Gloe T, Czabanka M, Kluter H, Augustin H, Vajkoczy P. Recruitment of human cord blood-derived endothelial colony-forming cells to sites of tumor angiogenesis. Cytotherapy. 2013;15(6):726\u201339.","journal-title":"Cytotherapy"},{"issue":"5","key":"936_CR23","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294\u2013301.","journal-title":"Stem Cells"},{"issue":"1","key":"936_CR24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/blood.V79.1.110.110","volume":"79","author":"W Durante","year":"1992","unstructured":"Durante W, Kroll MH, Vanhoutte PM, Schafer AI. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood. 1992;79(1):110\u20136.","journal-title":"Blood"},{"issue":"2","key":"936_CR25","first-page":"283","volume":"98","author":"T Goerge","year":"2007","unstructured":"Goerge T, Kleineruschkamp F, Barg A, Schnaeker EM, Huck V, Schneider MF, Steinhoff M, Schneider SW. Microfluidic reveals generation of platelet-strings on tumor-activated endothelium. Thromb Haemost. 2007;98(2):283\u20136.","journal-title":"Thromb Haemost"},{"issue":"1","key":"936_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.thromres.2012.02.041","volume":"130","author":"JF van Velzen","year":"2012","unstructured":"van Velzen JF, Laros-van Gorkom BA, Pop GA, van Heerde WL. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers. Thromb Res. 2012;130(1):92\u20138.","journal-title":"Thromb Res"},{"key":"936_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12967-015-0508-y","volume":"13","author":"H Abou-Saleh","year":"2015","unstructured":"Abou-Saleh H, Hachem A, Yacoub D, Gillis MA, Merhi Y. Endothelial progenitor cells inhibit platelet function in a P-selectin-dependent manner. J Transl Med. 2015;13:142.","journal-title":"J Transl Med"},{"issue":"22","key":"936_CR28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1161\/CIRCULATIONAHA.109.894642","volume":"120","author":"H Abou-Saleh","year":"2009","unstructured":"Abou-Saleh H, Yacoub D, Theoret JF, Gillis MA, Neagoe PE, Labarthe B, Theroux P, Sirois MG, Tabrizian M, Thorin E, et al. Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation. 2009;120(22):2230\u20139.","journal-title":"Circulation"},{"key":"936_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.05.002","volume":"75","author":"E Fuentes","year":"2015","unstructured":"Fuentes E, Palomo I. Extracellular ATP metabolism on vascular endothelial cells: a pathway with pro-thrombotic and anti-thrombotic molecules. Vasc Pharmacol. 2015;75:1\u20136.","journal-title":"Vasc Pharmacol"},{"key":"936_CR30","first-page":"728","volume":"9","author":"J Glenn","year":"2011","unstructured":"Glenn J, Iyu DE, White A, Fox S, Heptinstall S. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist. J Thromb Haemost. 2011;9:728.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"936_CR31","doi-asserted-by":"publisher","first-page":"F680","DOI":"10.1152\/ajprenal.00312.2014","volume":"307","author":"EK Jackson","year":"2014","unstructured":"Jackson EK, Cheng DM, Verrier JD, Janesko-Feldman K, Kochanek PM. Interactive roles of CD73 and tissue nonspecific alkaline phosphatase in the renal vascular metabolism of 5'-AMP. Am J Physiol Renal Physiol. 2014;307(6):F680\u20135.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"936_CR32","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/jcb.25909","volume":"118","author":"LIS Naasani","year":"2017","unstructured":"Naasani LIS, Rodrigues C, de Campos RP, Beckenkamp LR, Iser IC, Bertoni APS, Wink MR. Extracellular nucleotide hydrolysis in dermal and limbal mesenchymal stem cells: a source of adenosine production. J Cell Biochem. 2017;118(8):2430\u201342.","journal-title":"J Cell Biochem"},{"issue":"3","key":"936_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1160\/TH13-07-0581","volume":"111","author":"JR Glenn","year":"2014","unstructured":"Glenn JR, Dovlatova N, White AE, Dhillon K, Heptinstall S, Fox SC. \u2018VASPFix\u2019 for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y(12) antagonists. Thromb Haemost. 2014;111(3):539\u201348.","journal-title":"Thromb Haemost"},{"issue":"1","key":"936_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jcyt.2012.11.001","volume":"15","author":"M Karagianni","year":"2013","unstructured":"Karagianni M, Brinkmann I, Kinzebach S, Grassl M, Weiss C, Bugert P, Bieback K. A comparative analysis of the adipogenic potential in human mesenchymal stromal cells from cord blood and other sources. Cytotherapy. 2013;15(1):76\u201388.","journal-title":"Cytotherapy"},{"issue":"5","key":"936_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3109\/14653249.2011.652809","volume":"14","author":"K Bieback","year":"2012","unstructured":"Bieback K, Hecker A, Schlechter T, Hofmann I, Brousos N, Redmer T, Besser D, Kluter H, Muller AM, Becker M. Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum. Cytotherapy. 2012;14(5):570\u201383.","journal-title":"Cytotherapy"},{"issue":"9","key":"936_CR36","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/stem.139","volume":"27","author":"K Bieback","year":"2009","unstructured":"Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, Kluter H. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells. 2009;27(9):2331\u201341.","journal-title":"Stem Cells"},{"issue":"3","key":"936_CR37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/stem.2280","volume":"34","author":"E Kerkel\u00e4","year":"2016","unstructured":"Kerkel\u00e4 E, Laitinen A, Rabina J, Valkonen S, Takatalo M, Larjo A, Veijola J, Lampinen M, Siljander P, Lehenkari P, et al. Adenosinergic immunosuppression by human mesenchymal stromal cells requires co-operation with T cells. Stem Cells. 2016;34(3):781\u201390.","journal-title":"Stem Cells"},{"issue":"1","key":"936_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.scr.2011.04.001","volume":"7","author":"F Saldanha-Araujo","year":"2011","unstructured":"Saldanha-Araujo F, Ferreira FI, Palma PV, Araujo AG, Queiroz RH, Covas DT, Zago MA, Panepucci RA. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes. Stem Cell Res. 2011;7(1):66\u201374.","journal-title":"Stem Cell Res"},{"issue":"8","key":"936_CR39","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3727\/096368910X546553","volume":"20","author":"C Sattler","year":"2011","unstructured":"Sattler C, Steinsdoerfer M, Offers M, Fischer E, Schierl R, Heseler K, Daubener W, Seissler J. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplant. 2011;20(8):1221\u201330.","journal-title":"Cell Transplant"},{"issue":"6","key":"936_CR40","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/stem.2532","volume":"35","author":"PJ Schuler","year":"2017","unstructured":"Schuler PJ, Brandau S. Adenosine producing mesenchymal stem cells. Stem Cells. 2017;35(6):1647\u20138.","journal-title":"Stem Cells"},{"issue":"1","key":"936_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jcp.22379","volume":"226","author":"HA Johnston-Cox","year":"2011","unstructured":"Johnston-Cox HA, Yang D, Ravid K. Physiological implications of adenosine receptor-mediated platelet aggregation. J Cell Physiol. 2011;226(1):46\u201351.","journal-title":"J Cell Physiol"},{"issue":"2","key":"936_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0167-4889(96)00123-1","volume":"1355","author":"G Soslau","year":"1997","unstructured":"Soslau G, Youngprapakorn D. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta. 1997;1355(2):131\u201340.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"936_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4252\/wjsc.v6.i2.153","volume":"6","author":"S Scarfi","year":"2014","unstructured":"Scarfi S. Purinergic receptors and nucleotide processing ectoenzymes: their roles in regulating mesenchymal stem cell functions. World J Stem Cells. 2014;6(2):153\u201362.","journal-title":"World J Stem Cells"},{"issue":"2","key":"936_CR44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/ATVBAHA.110.219501","volume":"31","author":"D Iy\u00fa","year":"2011","unstructured":"Iy\u00fa D, Glenn JR, White AE, Fox SC, Heptinstall S. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y(12) antagonist. Arterioscler Thromb Vasc Biol. 2011;31(2):416\u201322.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"936_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/VHRM.S44469","volume":"11","author":"R Paniccia","year":"2015","unstructured":"Paniccia R, Priora R, Liotta AA, Abbate R. Platelet function tests: a comparative review. Vasc Health Risk Manag. 2015;11:133\u201348.","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"936_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.imbio.2016.01.013","volume":"222","author":"PJ Schuler","year":"2017","unstructured":"Schuler PJ, Westerkamp AM, Kansy BA, Bruderek K, Dissmann PA, Dumitru CA, Lang S, Jackson EK, Brandau S. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma. Immunobiology. 2017;222(1):66\u201374.","journal-title":"Immunobiology"},{"issue":"7","key":"936_CR47","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.otsr.2016.07.006","volume":"102","author":"E Raposio","year":"2016","unstructured":"Raposio E, Bonomini S, Calderazzi F. Isolation of autologous adipose tissue-derived mesenchymal stem cells for bone repair. Orthop Traumatol Surg Res. 2016;102(7):909\u201312.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"10","key":"936_CR48","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/jcb.24830","volume":"115","author":"IC Iser","year":"2014","unstructured":"Iser IC, Bracco PA, Goncalves CEI, Zanin RF, Nardi NB, Lenz G, Battastini AMO, Wink MR. Mesenchymal stem cells from different murine tissues have differential capacity to metabolize extracellular nucleotides. J Cell Biochem. 2014;115(10):1673\u201382.","journal-title":"J Cell Biochem"},{"issue":"4","key":"936_CR49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.18388\/abp.2003_3627","volume":"50","author":"E Gendaszewska-Darmach","year":"2003","unstructured":"Gendaszewska-Darmach E, Maszewska M, Zaklos M, Koziolkiewicz M. Degradation of extracellular nucleotides and their analogs in HeLa and HUVEC cell cultures. Acta Biochim Pol. 2003;50(4):973\u201384.","journal-title":"Acta Biochim Pol"},{"key":"936_CR50","first-page":"1","volume":"73","author":"LD Christensen","year":"1997","unstructured":"Christensen LD. CD73 (ecto-5\u2032-nucleotidase) on blood mononuclear cells. Regulation of ecto-5\u2032-nucleotidase activity and antigenic heterogeneity of CD73 on blood mononuclear cells from healthy donors and from patients with immunodeficiency. APMIS Suppl. 1997;73:1\u201328.","journal-title":"APMIS Suppl"},{"issue":"25","key":"936_CR51","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1091\/mbc.e14-06-1167","volume":"25","author":"NT Snider","year":"2014","unstructured":"Snider NT, Altshuler PJ, Wan S, Welling TH, Cavalcoli J, Omary MB. Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5\u2032-nucleotidase (CD73). Mol Biol Cell. 2014;25(25):4024\u201333.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"936_CR52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.38959","volume":"67","author":"S Botta Gordon-Smith","year":"2015","unstructured":"Botta Gordon-Smith S, Ursu S, Eaton S, Moncrieffe H, Wedderburn LR. Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis. Arthritis Rheumatol. 2015;67(2):545\u201354.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"936_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1699-0463.1996.tb00697.x","volume":"104","author":"LD Christensen","year":"1996","unstructured":"Christensen LD. No correlation between CD73 expression and ecto-5\u2032-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5\u2032-nucleotidase) on blood mononuclear cells with distinct antigenic properties. APMIS. 1996;104(2):126\u201334.","journal-title":"APMIS"},{"issue":"1","key":"936_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1634\/stemcells.2008-0363","volume":"27","author":"MR Kim","year":"2009","unstructured":"Kim MR, Jeon ES, Kim YM, Lee JS, Kim JH. Thromboxane a(2) induces differentiation of human mesenchymal stem cells to smooth muscle-like cells. Stem Cells. 2009;27(1):191\u20139.","journal-title":"Stem Cells"},{"issue":"1","key":"936_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3858\/emm.2009.41.1.003","volume":"41","author":"DH Yun","year":"2009","unstructured":"Yun DH, Song HY, Lee MJ, Kim MR, Kim MY, Lee JS, Kim JH. Thromboxane a(2) modulates migration, proliferation, and differentiation of adipose tissue-derived mesenchymal stem cells. Exp Mol Med. 2009;41(1):17\u201324.","journal-title":"Exp Mol Med"},{"issue":"4","key":"936_CR56","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1634\/stemcells.22-4-625","volume":"22","author":"K Bieback","year":"2004","unstructured":"Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625\u201334.","journal-title":"Stem Cells"},{"issue":"6","key":"936_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.cellbi.2005.12.009","volume":"30","author":"YJ Chang","year":"2006","unstructured":"Chang YJ, Tseng CP, Hsu LF, Hsieh TB, Hwang SM. Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int. 2006;30(6):495\u20139.","journal-title":"Cell Biol Int"},{"issue":"5","key":"936_CR58","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/01.ATV.13.5.696","volume":"13","author":"A Zatta","year":"1993","unstructured":"Zatta A, Pandolfo L, Caparrotta L, Prosdocimi M, Dejana E, Delmaschio A. Platelet-aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity. Arterioscler Thromb. 1993;13(5):696\u2013701.","journal-title":"Arterioscler Thromb"},{"issue":"2","key":"936_CR59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jss.2006.11.006","volume":"143","author":"KM Patel","year":"2007","unstructured":"Patel KM, Crisostomo P, Lahm T, Markel T, Herring C, Wang M, Meldrum KK, Lillemoe KD, Meldrum DR. Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism. J Surg Res. 2007;143(2):281\u20135.","journal-title":"J Surg Res"},{"issue":"24","key":"936_CR60","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1007\/s00018-015-2035-7","volume":"72","author":"B Heissig","year":"2015","unstructured":"Heissig B, Dhahri D, Eiamboonsert S, Salama Y, Shimazu H, Munakata S, Hattori K. Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression. Cell Mol Life Sci. 2015;72(24):4759\u201370.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"936_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000215579","volume":"191","author":"S Neuss","year":"2010","unstructured":"Neuss S, Schneider RKM, Tietze L, Knuchel R, Jahnen-Dechent W. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots. Cells Tissues Organs. 2010;191(1):36\u201346.","journal-title":"Cells Tissues Organs"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-0936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-0936-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-0936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T03:05:56Z","timestamp":1604545556000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-0936-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-0936-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"9 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Platelet donors were volunteer healthy persons giving informed consent, who had not been taking any platelet inhibiting medication for at least 2 weeks. The Mannheim Ethics Commission II confirmed that the regular blood donor questionnaire and informed consent documentation waives the need for ethical approval.MSC experiments were approved by the Mannheim Ethics Commission II (vote numbers 2010-262\u00a0N-MA, 2009-210\u00a0N-MA, 49\/05 and 48\/05).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PW receives honoraria from and has membership on Advisory Boards for Sanofi-Aventis. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"184"}}